FindTrial
Sign In

To study effectiveness of shringyadi lozenges and bharangyadi lozenges in the management of vataj kasa for 7 days in the children of age group 5-12 years

A comparative clinical study to evaluate the efficacy of shringyadi lozenges and bharangyadi lozenges in the management of vataj kasa in the children of age group 5-12 years for 7 days

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085356
Enrollment
110
Registered
2025-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J989- Respiratory disorder, unspecified

Interventions

None listed

Sponsors

Sane Guruji Arogya Kendra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient having classical signs and symptoms of vataj kasa i.e Urashool, Shirshoola, Swarbhed, Shushka kasa, Mukhshushkata, Prasaktaveg, Kanthakshobh, Kruchchat muktwa alpata vrajet. Age group 5 yr to 12 yr. Patients of both sex irrespective of religion and socioeconomical status. Parent who give written consent will be included.

Exclusion criteria

Exclusion criteria: Cough associated with known case of pneumonia, severe bronchial asthma, tuberculosis, whopping cough, severe viral infections, chronic respiratory disorder, patient with respiratory distress, tachypnea, malnutrition will be excluded.

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of Shringyadi lozenges and Bharangyadi lozenges in the management of Vataj Kasa in children of age group 5-12 years for 7 days.Timepoint: Treatment will be given for 7 days lozenges will be given for 7 days Follow up and assessment will be done on 1st 4th 7th day—

Secondary

MeasureTime frame
To study adverse effect of Shringyadi lozenges and Bharangyadi lozenges if any.Timepoint: Treatment will be given for 7 days lozenges will be given for 7 days Follow up and assessment will be done on 1st 4th 7th day Adverse effect will be notice and noted—

Countries

India

Contacts

Public ContactDr Manisha Jagtap

MAM S Sumatibhai Shah Ayurved Mahavidyalaya Malwadi Hadapsar Pune

Manisha.shinde18@gmail.com8412022555

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026